Aekyung Petrochemical Co., Ltd. Overview
Aekyung Chemical is the chemicals arm of Korea's Aekyung Group and the country's largest producer of phthalic anhydride and plasticizers by capacity. The 2021 three-way merger added unsaturated polyester and coating resins, surfactants and a biodiesel/bio-heavy-oil business, giving four operating segments. The legacy portfolio is commodity-like and has been squeezed by Chinese capacity additions: consolidated revenue fell from KRW 2.18 trillion in 2022 to KRW 1.45 trillion in 2025, when the company posted an operating loss. Management's response is a pivot to specialty materials: Korea's first domestic terephthaloyl chloride (TPC) plant for aramid fibre (15,000 t/y, Ulsan), hard-carbon anode material for sodium-ion batteries (Jeonju), and an Indonesian surfactant plant bought from Evonik. First-half 2026 results show a sharp recovery from a very low base. The investment case rests on whether these new lines reach commercial scale.
Company description. DART-derived profiles describe the company as having absorbed Aekyung Chemical (old) and AK ChemTech to expand into four strategic operating segments (plasticizers, synthetic resins, household chemicals, and bio & energy) with a focus on environmentally friendly products. Main products named are phthalic anhydride, coating resins, surfactants and biodiesel. WiseReport notes eleven consolidated subsidiaries.
Independent characterization. This is a mid-cap, product-sales chemical manufacturer. Revenue is essentially 100% product sales; there is no subscription or licensing revenue of note (licensing income: not publicly disclosed). The company sits mid-stream: it buys petrochemical feedstocks (ortho-xylene, alcohols, styrene monomer, glycols, vegetable oils and waste oils) and sells intermediates and formulated chemicals to industrial customers. Margins are spread-driven and cyclical.
Value chain and customers.
Geographically, the company operates in South Korea, Vietnam and China (Simply Wall St), with Indonesia added in October 2025.
Strategy
Strategic themes from management statements and press (2025–2026): shift from commodity to specialty; localisation of imported advanced materials; next-generation battery materials; overseas production bases; eco-friendly products at 50% of the portfolio by 2030.
Timeline slippage is material: TPC mass production was first guided for January 2026, then March 2026, then first-half 2026, and is now October 2026. Formal numeric guidance for 2026: not publicly disclosed.
Products & Services
Pricing is spot and contract, negotiated; no list pricing is disclosed. Launch years are not disclosed except where stated.
Plasticizers segment
Synthetic Resins segment
Household Chemicals segment
Bio & Energy segment
Product list drawn from the Simply Wall St company description and Korean press; grade-level specifications are not publicly disclosed in the sources reviewed.
Product Portfolio
| Product | Description | Target customer |
|---|---|---|
Phthalic anhydride (PA) | Core intermediate from ortho-xylene; feedstock for plasticizers, resins, pigments; company is Korea's largest by capacity | Plasticizer, resin and pigment makers |
General-purpose plasticizers | Phthalate types (DOP, DINP class) | PVC flooring, wallcovering, film, cable |
Functional and eco-friendly plasticizers | Non-phthalate types (DOTP class and specialty grades) | Medical, toys, food-contact, automotive |
Maleic anhydride | Intermediate for unsaturated polyester resins | Resin makers |
Itaconic acid | Specialty acid monomer | Polymer and additive makers |
Lubricant base oils | Synthetic ester base stocks | Lubricant blenders |
TPC (terephthaloyl chloride) | — | Aramid fibre producers |
| Product | Description | Target customer |
|---|---|---|
Unsaturated polyester resins | Resins for composite materials | FRP moulders: marine, tanks, construction |
Coating resins | Resins for paints | Paint manufacturers |
Adhesives | Industrial adhesive resins | Packaging, lamination |
Polyisocyanate hardener | Isocyanate curing agent | Coatings, polyurethane |
Polyester polyol | Aromatic-structure polyol for urethane systems | Insulation and foam makers |
| Product | Description | Target customer |
|---|---|---|
Surfactants | Anionic and non-ionic surfactants; Korean, Vietnamese and (from October 2025) Indonesian production | Detergent and personal care formulators |
| Product | Description | Target customer |
|---|---|---|
Biodiesel | Blending component under Korea's renewable fuel standard | Refiners |
Bio-heavy oil | Power-generation fuel; demand tied to the Renewable Portfolio Standard | Power generators |
Hard carbon anode material (AHC-3 series) | Biomass-based anode material for sodium-ion batteries; pilot output and customer evaluation under way | Battery makers |
Financial Narrative
Consolidated, K-IFRS.
Income statement
Margins
Notes: FY2022 margins are calculated. The vendor series (valueinvesting.io) appears to use net income attributable to controlling shareholders, which explains the FY2024–FY2025 differences. Preliminary press reports put the FY2025 operating loss at KRW 10.1 billion; the company IR page shows KRW 10.2 billion. Revenue CAGR FY2022–FY2025: -12.6% (calculated).
Balance sheet
Dividends implied at about KRW 6.8 billion for FY2025 (140 x 48.28M shares, calculated).
Ratios
Asset turnover is calculated on year-end assets.
Interim results
The H1 2026 absolute values are derived by applying the reported growth rates to rounded H1 2025 figures and are sensitive to rounding; confirm against the half-year report.
Commentary. Revenue has fallen three years running, a cumulative KRW 724 billion, or one third, from the 2022 peak. The driver is the plasticizer chain, where Chinese capacity additions compressed prices and displaced domestic volume. Operating profit moved from KRW 95.1 billion to a KRW 10.2 billion loss, and EBITDA fell by two thirds. The balance sheet moved the other way: total assets grew each year while equity shrank in 2025, so liabilities to equity rose 17 points in two years, consistent with debt-funded capex on the TPC plant and the Indonesian acquisition during an earnings trough. The parent-only accounts stayed marginally profitable in 2025 (operating profit KRW 1.3 billion, net income KRW 2.2 billion), which locates the 2025 loss in the consolidated subsidiaries. The FY2024 dividend of KRW 281 per share exceeded earnings more than threefold; the FY2025 cut to KRW 140 was still paid out of a loss, underlining the parent holding company's reliance on upstream dividends. First-half 2026 marks the inflection, helped by bio-heavy-oil demand and a low base.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment revenue
| Segment revenue | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
Plasticizers (KRW 100M) | 10,147 | — | 7,813 |
Bio & Energy (KRW 100M) | 3,760 | — | 2,640 |
Consolidated total (KRW 100M) | 21,764 | 17,937 | 16,422 |
Share of consolidated revenue
| Share of consolidated revenue | FY2022 | FY2024 |
|---|---|---|
Plasticizers (%) | 46.6 | 47.6 |
Bio & Energy (%) | 17.3 | 16.1 |
Income Statement (KRW) and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Revenue (KRW 100M) | 21,764 | 17,937 | 16,422 | 14,523 |
Operating income (KRW 100M) | 951 | 451 | 155 | -102 |
EBITDA (KRW 100M) | 1,280 | — | 530 | 419 |
Net income (KRW 100M) | 594 | 330 | 85 | -49 |
EPS basic (KRW) | — | — | — | -61 |
Dividend per share (KRW) | — | 250 | 281 | 140 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating margin (%) | — | 4.37 | 2.51 | 0.94 | -0.70 |
EBITDA margin (%) | — | 5.88 | — | 3.23 | 2.89 |
Net margin, company basis (%) | — | 2.73 | 1.84 | 0.52 | -0.34 |
Net margin, vendor basis (%) | 4.93 | 2.76 | 1.85 | 0.24 | -0.20 |
Balance Sheet (KRW)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Total assets (KRW 100M) | 13,084 | 13,564 | 13,943 |
Total liabilities (KRW 100M) | 5,720 | 6,155 | 6,779 |
Total equity (KRW 100M) | 7,363 | 7,410 | 7,164 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
ROE (%) | 4.52 | 0.54 | -0.41 |
ROA (%) | 2.59 | 0.64 | -0.36 |
Liabilities to equity (%) | 77.69 | 83.07 | 94.63 |
Asset turnover (x) | 1.37 | 1.21 | 1.04 |
Dividend payout (%) | 36.46 | 340.74 | -229.21 |
Dividend yield (%) | 1.63 | 4.11 | 1.47 |
Revenue History
| Period | Revenue (KRW 100M) | Operating income (KRW 100M) | Net income (KRW 100M) | Source |
|---|---|---|---|---|
H1 2025 | 7,462 | 27 | — | Dealsite |
Q4 2025 | 3,484 | — | -106 | GoInsider (amended filing) |
Q1 2026 | 3,706 | 58 | -14 | DART-derived aggregator |
H1 2026 | about 8740 (derived) | about 495 (derived) | Positive | WiseReport: revenue +17.1%, operating profit +1,732.8% YoY |
Revenue by Region (KRW)
| Metric | FY2022 | FY2024 |
|---|---|---|
Plasticizer segment, domestic revenue (KRW 100M) | 4,692 | 1,935 |
Plasticizer segment, export and overseas revenue (KRW 100M, derived) | 5,455 | 5,878 |
Revenue by Region (KRW) (Half-Yearly)
| Metric | H1 2024 | H1 2025 |
|---|---|---|
Bio & Energy revenue (KRW 100M) | 1,315 | 842 |
Valuation Snapshot
| Metric | Value | Date / source |
|---|---|---|
Share price | KRW 10,260 (prior close) | WiseReport, September 2026 |
Share price | KRW 9,200 | 26 June 2026, Investing.com |
Market capitalisation | About KRW 495 billion | Derived |
P/E | Not meaningful (trailing loss; EPS KRW -61) | WiseReport |
P/B | 0.69 (BPS KRW 14,790) | WiseReport |
EV/EBITDA | 21.81 (FY2025) | WiseReport |
EV/Sales | About 0.6 (derived from EV/EBITDA and EBITDA; approximate) | Calculated |
Dividend yield | 1.36% | WiseReport |
Analyst coverage | Three or fewer brokers (LS Securities "low coverage" list, 2024); no consensus estimates | LS Securities; Simply Wall St |
Dividend history
| Dividend history | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Dividend per share (KRW) | 250 | 281 | 140 |
Payout ratio (%) | 36.46 | 340.74 | -229.21 |
Analyst Conclusions
Guidance. No numeric guidance for 2026 was found. Management targets ROE above 8% by 2027 and positions 2026 as the year TPC and hard carbon begin to generate sales.
Bull case
-
First-half 2026 operating profit of roughly KRW 49–50 billion (derived) already exceeds full-year 2023, showing operating leverage when spreads and bio-fuel demand recover.
-
TPC adds a higher-margin, import-substituting product with a protected local position from October 2026.
-
At 0.69 times book, the shares price in little value for hard carbon or Southeast Asian expansion.
Bear case
-
The core plasticizer business faces structural, not cyclical, Chinese oversupply; domestic segment sales fell 59% in two years.
-
Leverage rose through the trough, and the parent holding company's need for dividends competes with capex.
-
New businesses have slipped repeatedly and have no disclosed offtake contracts; the FTC probe is unresolved.
Catalysts and monitorables (next 12 months). Q3 2026 report by 16 November 2026; TPC utilisation and first disclosed supply volumes; completion of the 1,300 t/y hard carbon line and customer qualification; FTC decision; FY2026 dividend; Indonesian plant contribution; any AK Holdings restructuring.
Analyst verdict. Aekyung Chemical is a commodity intermediates business in the middle of an attempted conversion to specialty materials, and the evidence so far supports the diagnosis more than the cure. The diagnosis is clear in the numbers: a third of revenue lost since 2022, EBITDA down by two thirds, and a first consolidated operating loss in 2025, all traceable to Chinese plasticizer capacity that is unlikely to retreat. The cure consists of three projects. TPC is the most credible: the plant is built, the company is the only domestic supplier, and Korean aramid producers have a logistical reason to buy locally. Its weakness is a start-up timetable that moved four times in a year and the absence of any disclosed contract. Hard carbon is an option on sodium-ion adoption, with value only if pilot customers convert. Indonesia is sensible but small. Against this, the 2026 rebound is real but owes much to bio-heavy-oil demand and a depressed base, and the sustainability of that segment is clouded by an antitrust investigation. The balance sheet remains sound in absolute terms, yet leverage has risen while dividends were paid out of losses, a pattern that reflects the parent's needs more than the subsidiary's. On balance the shares look like a low-priced, thinly traded recovery situation with asymmetric dependence on one plant. The next two quarterly reports, which should show TPC revenue for the first time, will decide whether the specialty narrative deserves a multiple above book value. Until then, the appropriate stance is cautious and evidence-led.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Role | Notes |
|---|---|---|
Pyo Kyung-won (표경원) | Chief Executive Officer | — |
Seong-wan Kim | Listed as CEO by Simply Wall St | Conflicts with Korean sources; possibly a co-representative director or stale vendor data; unresolved |
Chae Hyung-seok | Aekyung Group vice chairman; largest individual shareholder of AK Holdings (14.25% as of 2021) | Group-level controller, not confirmed as a director of the company |
Competitive Landscape
Competitors by Segment
| Segment | Named competitors |
|---|---|
Phthalic anhydride and plasticizers | LG Chem, Hanwha Solutions, OCI, UPC Technology, Nan Ya Plastics, Bluesail, Eastman, BASF, Evonik |
Synthetic resins | Kukdo Chemical, KCC, Polynt, AOC |
Surfactants | Miwon Commercial, LG Household & Health Care (captive), Kao, Stepan |
Biodiesel and bio-heavy oil | SK Eco Prime, GS Bio, Dansuk Industrial, JC Chemical |
TPC | Chinese and Japanese import suppliers (previously 100% of Korean supply) |
Hard carbon | Kuraray, BTR, other Chinese anode makers |



